| Date | Title | Description |
| 11.09.2025 | Octave Bioscience Secures Major Funding for Precision Neurology Advancement | Octave Bioscience secured $51.1 million in fresh capital. This includes a $35.6 million Series C equity round and a $15.5 million debt facility. Funds accelerate MSDA test commercialization. This blood-based diagnostic tool measures Multipl... |
| 10.09.2025 | Octave Bioscience: $35 Million Raised For Advancing Precision Care For Neurological Diseases | Octave Bioscience, a company focused on precision medicine for neurodegenerative conditions, has announced the successful close of a $35.6 million Series C equity financing round. In addition to this funding, the company has secured a $15.5... |
| 05.09.2025 | Sola Security: $35 Million Series A Raised For Cybersecurity Technology | Sola Security, a rapidly growing innovator in cybersecurity technology, has announced the close of its $35 million Series A funding round. The round was led by existing investor S32 and joined by M12, Microsoft’s venture arm, along with New... |
| 05.09.2025 | Octave Bioscience Raises $35M in Series C Financing | Octave Bioscience, a Menlo Park, CA-based commercial stage precision care company, announced the close of its $35.6M Series C equity financing and that it has entered into a $15.5M non-dilutive term loan agreement with Silicon Valley Bank (... |
| 04.09.2025 | Ex-GV head aims for $600m for S32’s sixth fund | - |
| 03.06.2025 | Infleqtion's Quantum Leap: $100 Million to Revolutionize Technology | In the heart of Boulder, Colorado, a quantum revolution is brewing. Infleqtion, a company born from the academic halls of the University of Colorado, has just secured a staggering $100 million in Series C funding. This infusion of capital i... |
| 02.06.2025 | Infleqtion closes $100M Series C round | Infleqtion, a quantum technology company that uses lasers to maintain those systems, has fetched roughly $100 million in Series C capital from investors to aid in the further development and scaling of its product offerings.
Founded as cold... |
| 12.05.2025 | Inductive Bio: Pioneering the Future of Drug Discovery with $25 Million Series A Funding | In the bustling heart of New York City, a quiet revolution is brewing. Inductive Bio, a trailblazer in artificial intelligence (AI) for small molecule drug discovery, has secured $25 million in Series A funding. This financial boost, led by... |
| 11.05.2025 | Inductive Bio: $25 Million Series A Closed To Transform Small Molecule Drug Discovery | Inductive Bio, a company democratizing AI models to transform small molecule drug discovery, announced that it has raised $25 million in Series A funding led by Obvious Ventures with participation from Andreessen Horowitz (a16z) Bio + Healt... |
| 07.04.2025 | SandboxAQ Closes Series E Round with Expanded Investor Base | New investments to accelerate SandboxAQ’s innovation in quantitative AI and expand its impact across critical industries
SandboxAQ, a global leader in enterprise quantitative AI, announced the addition of Ray Dalio, Horizon Kinetics, BNP Pa... |
| 07.04.2025 | SandboxAQ Closes Series E Funding Round | SandBoxAQ, a Palo Alto, CA-based enterprise quantitative AI company, raised an undisclosed amount in Series E funding.
Latest investors included Ray Dalio, Horizon Kinetics, BNP Paribas, Google, and NVIDIA, bringing the total amount to over... |
| 05.04.2025 | SandboxAQ: Over $450 Million (Series E) Raised For Enterprise Quantitative AI | SandboxAQ, a leader in enterprise quantitative AI, announced the addition of Ray Dalio, Horizon Kinetics, BNP Paribas, Google, and NVIDIA to its Series E funding round that raised over $450 million. These investments emphasize the confidenc... |
| 04.04.2025 | SandboxAQ Adds $150M From Google, Nvidia And Others | 0 Shares Email Facebook Twitter LinkedIn
Alphabet spinoff SandboxAQ — an AI and quantum computing startup — added another $150 million to its Series E from the likes of Google and Nvidia.
The add-on comes less than four months after the com... |
| 31.03.2025 | Character Biosciences: Pioneering Precision Medicine for Eye Diseases | In the realm of healthcare, precision medicine is the compass guiding us toward targeted therapies. Character Biosciences, a New Jersey-based company, is at the forefront of this revolution. Recently, they secured a hefty $93 million in Ser... |
| 28.03.2025 | Character Biosciences: $93 Million (Series B) Secured For Advancing Precision Medicine For Progressive Eye Diseases | Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, announced an oversubscribed $93 million Series B financing round to accelerate the advancement of its pipeline of precision therapies ... |
| 12.03.2025 | Sola Security: A New Dawn in Cybersecurity | In a world where cyber threats loom like dark clouds, Sola Security emerges as a beacon of hope. This Tel Aviv-based startup has just raised $30 million in seed funding, marking its debut from stealth mode. The funding round was led by S Ca... |
| 11.03.2025 | Sola Security Raises $30M in Seed Funding | Sola Security, a Tel Aviv, Israel-based self-serve cybersecurity platform provider, launched from stealth today with a $30m seed funding.
The round was led by S Capital and Mike Moritz with participation from S32, Glilot Capital Partners, a... |
| 19.12.2024 | SandboxAQ: AI And Quantum Solutions Company Announces Over $300 Million Funding At $5.3 Billion Valuation | SandboxAQ announced a funding round of over $300 million from Fred Alger Management, LLC, T. Rowe Price Associates, Mumtalakat, Parkway Venture Capital, Breyer Capital, Rizvi Traverse, S32, US Innovative Technology Fund, Ava Investments, Er... |
| 18.12.2024 | SandboxAQ Raises More Than $300M in Funding | SandboxAQ, a Palo Alto, CA-based company delivering solutions at the intersection of AI and quantum techniques, raised more that $300M in funding.
The round, which valued the company at $5.3 billion on a pre-money basis, was led by Fred Alg... |
| 18.12.2024 | SandboxAQ raises $300M at $5.6B valuation to develop AI and quantum technology
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to pr... | SandboxAQ, a company that develops artificial intelligence and quantum sensing technology, announced today that it has raised more than $300 million in new funding at a valuation of more than $5.6 billion to accelerate the development of sp... |
| 22.10.2024 | Sunbird Bio: $14 Million Closed To Advance Blood-Based Diagnostic Platform In Alzheimer’s Disease | Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve the diagnosis and treatment of neurological disorders and early-stage cancer, announced the closing of a $14 million financing round backed by t... |
| 26.03.2024 | Brightside Health Secures $33M to Expand Access to Mental Healthcare | What You Should Know:
– Brightside Health, a teletherapy provider for depression, anxiety, and other mood disorders, raises $33M in Series C funding led by S32.
– The funding round, which included participation from existing investors along... |
| 13.03.2024 | IVF uncertainty aside, startups rush to offer fertility care amid rising demand | AI tools, egg freezing, surrogacy, IUI, donorship, oncofertility, genetic analysis, loans, and more
In the aftermath of the Roe v. Wade overturn, U.S. fertility clinics (and patients alongside them) are battling an unlikely complication in ... |
| 27.02.2024 | Freenome scores $254M to advance its cancer-detection blood tests | The San Francisco company readies to reveal its first clinical study results in the near term
When it comes to cancer, spotting it early can make a big difference on treatment options and survival. Commonly a progressive disease, certain un... |
| 20.02.2024 | Freenome's $254M Boost for Early Cancer Detection | Freenome, a biotech company in San Francisco, just secured a massive $254M in funding to advance their blood-based cancer detection tests. The investment, led by Roche and backed by a slew of other big names, will propel Freenome's mission ... |
| 15.02.2024 | Freenome Raises $254M to Accelerate Early Cancer Detection Platform | What You Should Know:
– Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was led by Roche with parti... |
| 06.10.2023 | Section 32 Closes $525M Fund 5 | Section 32, a Palo Alto, CA-based venture capital firm, closed its Fund 5, at $525M.
The fund will invest in companies that are pushing the boundaries in software and artificial intelligence (“AI”) to enable new capabilities and step-change... |
